Glaucoma treatment qls 101 in Minneapolis, Minnesota

The Institute for Therapeutics Discovery and Development, located at 717 Delaware Street Southeast in Minneapolis, Minnesota, is a leading institution dedicated to advancing pioneering research in drug discovery and early pre-clinical drug development. Collaborating with various schools, colleges, and research centers, as well as industrial partners nationwide, the institute creates opportunities for groundbreaking discoveries in the field of pharmaceutical sciences. One of the notable achievements of the institute includes the development of YCT-529, a hormone-free male birth control pill, which has shown promising results in clinical trials. Additionally, the institute has been involved in the successful Phase 2 clinical trials of glaucoma drug QLS-101, demonstrating a favorable safety profile and efficacy signal.